EyePoint Pharmaceuticals, Inc. Quarterly Return On Assets in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q3 2024.
  • EyePoint Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -31.6 %, a 47% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Return On Assets for 2023 was -33.5 %, a 28% increase from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Return On Assets for 2022 was -46.5 %, a 58.8% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Return On Assets for 2021 was -29.3 %, a 48.6% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -31.6 +28.1 +47% Jul 1, 2024 Sep 30, 2024
Q2 2024 -29.7 +28.3 +48.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -30.9 +21 +40.4% Jan 1, 2024 Mar 31, 2024
Q4 2023 -33.5 +13.1 +28% Oct 1, 2023 Dec 31, 2023
Q3 2023 -59.7 -27.2 -83.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -58 -24.3 -72.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -51.9 -20.6 -65.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 -46.5 -17.2 -58.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -32.5 +2.26 +6.49% Jul 1, 2022 Sep 30, 2022
Q2 2022 -33.6 -2.54 -8.17% Apr 1, 2022 Jun 30, 2022
Q1 2022 -31.4 +10.5 +25% Jan 1, 2022 Mar 31, 2022
Q4 2021 -29.3 +27.7 +48.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -34.8 +19 +35.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -31.1 +38 +55% Apr 1, 2021 Jun 30, 2021
Q1 2021 -41.9 +20.9 +33.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -57 +12.8 +18.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -53.8 +16.4 +23.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -69.1 +19.6 +22.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -62.7 +60.1 +48.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -69.9 +49.4 +41.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -70.2 +72.7 +50.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -88.7 +53.7 +37.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -123 -19.6 -19% Jan 1, 2019 Mar 31, 2019
Q4 2018 -119 +25.3 +17.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 -143 -42.9 -42.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -142 -51 -55.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -103 -23.2 -29% Jan 1, 2018 Mar 31, 2018
Q4 2017 -145 -78.2 -118% Oct 1, 2017 Dec 31, 2017
Q3 2017 -100 -18.4 -22.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -91.4 -19.1 -26.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 -80 -12.3 -18.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -66.4 +1.48 +2.18% Oct 1, 2016 Dec 31, 2016
Q3 2016 -81.5 -25.1 -44.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 -72.3 -89 -533% Apr 1, 2016 Jun 30, 2016
Q1 2016 -67.7 -88.9 -420% Jan 1, 2016 Mar 31, 2016
Q4 2015 -67.8 -99 -318% Oct 1, 2015 Dec 31, 2015
Q3 2015 -56.5 -94.9 -247% Jul 1, 2015 Sep 30, 2015
Q2 2015 16.7 +74.6 Apr 1, 2015 Jun 30, 2015
Q1 2015 21.2 +83.3 Jan 1, 2015 Mar 31, 2015
Q4 2014 31.2 +102 Oct 1, 2014 Dec 31, 2014
Q3 2014 38.5 +104 Jul 1, 2014 Sep 30, 2014
Q2 2014 -57.9 +1.78 +2.98% Apr 1, 2014 Jun 30, 2014
Q1 2014 -62.2 -13.6 -27.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -70.7 -24.6 -53.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 -65.9 +43 +39.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -59.7 +29.4 +33% Apr 1, 2013 Jun 30, 2013
Q1 2013 -48.6 +17.2 +26.2% Jan 1, 2013 Mar 31, 2013
Q4 2012 -46 Oct 1, 2012 Dec 31, 2012
Q3 2012 -109 Jul 1, 2012 Sep 30, 2012
Q2 2012 -89.1 Apr 1, 2012 Jun 30, 2012
Q1 2012 -65.8 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.